Neuren drug finally been cleared by FDA in USA
SYDNEY: Australia’s top performing health stock for 2022, Neuren, has gained clearance from the US
SYDNEY: Australia’s top performing health stock for 2022, Neuren, has gained clearance from the US
FEATURED
Former city mortuary is now taking new senior residents
Best affordable housing design for Global Awards shortlisted
Planning authorities take wrecking ball to boomer projects
Best social housing community design for Global Awards shortlisted
Couple takes on new adventure as caretakers of the island
Seniors will soon find affordable housing in affluent neighborhood
INNOVATION
